Turn Therapeutics Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 10.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 319.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Details
| Name | Turn Therapeutics Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2 |
| Founded | 2015 |
| Ceo | Bradley Burnam |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US90021W1053 |
| Cusip | 90021W105 |
| Cik | 2023016 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Mohammed Zubair | Controller |
| Dr. Stephen M. Hahn FASTRO, M.D. | Executive Clinical and Regulatory Lead |
Contact
| Address | 250 N Westlake Blvd, STE 210, Westlake Village, California 91362, United States |
| Phone | 818 546 4011 |
| Website | https://turntherapeutics.com |